🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationState pharmacy board compounding enforcement actions — anyone have experience? Page 2

State pharmacy board compounding enforcement actions — anyone have experience?

MariaRD Sat, Feb 8, 2025 at 10:53 AM 9 replies 1,486 viewsPage 2 of 2
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Feb 8, 2025 at 1:43 PM#6

This is super helpful. So the bottom line is: if I want the smoothest experience, I should find a 503B outsourcing facility that's licensed in my state, rather than trying to use a local 503A pharmacy?

12 17denise_HTX, raj_cambridge, ingrid_STO and 9 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Feb 8, 2025 at 2:00 PM#7

Generally yes, for GLP-1 peptides specifically. 503B facilities have the federal registration that smooths over most state-to-state issues. Just verify they're licensed in your state before placing an order — most will list their state licenses on their website.

And keep in mind this landscape changes constantly. What's true today might not be true in 6 months, especially with FDA enforcement actions ramping up.

Last edited: Feb 8, 2025 at 4:00 PM
42 24Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 39 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Feb 8, 2025 at 2:17 PM#8

One more thing — regardless of which state you're in, always check the FDA's list of registered outsourcing facilities. If a 503B claims to be registered but isn't on that list, that's a major red flag. The list is publicly available and searchable. Takes 2 minutes to verify. 📋

18 2NicoleRaleigh, james_edin, FranDenver and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register